Key Takeaways
- • Mosaic Intelligence Labs emerged from stealth with $47 million in seed funding to develop sensing-enabled spatial intelligence and robotic infrastructure for surgery.
- • Backers include 8VC, Fundomo, Lingotto Innovation, and Obvious Ventures, per the company's announcement as reported in the primary source.
- • Mosaic is building full-stack intelligent surgical machines, starting with endovascular intervention, where physicians guide flexible wires and catheters through blood vessels.
- • The company's stated aim is to extend the reach and precision of surgical expertise by helping physicians understand and safely navigate the body from within.
Summary
Mosaic Intelligence Labs, based in San Francisco, has emerged from stealth with $47 million in seed funding. The company is developing sensing-enabled spatial intelligence and robotic infrastructure intended to help physicians understand and safely navigate the human body from within, according to the primary source announcement.
The seed round is backed by investors including 8VC, Fundomo, Lingotto Innovation, and Obvious Ventures. The funding will support Mosaic's development of full-stack intelligent surgical machines designed to extend the reach and precision of surgical expertise.
Mosaic's initial focus is endovascular intervention, a category of procedures in which physicians guide flexible wires and catheters through blood vessels to deliver treatment. Targeting this segment first positions the company in a area of minimally invasive care where precision navigation is central to clinical outcomes.
The source material does not provide further detail on valuation, timeline to clinical deployment, regulatory status, or leadership, and this summary does not extrapolate beyond the announced funding and product direction.
The seed round is backed by investors including 8VC, Fundomo, Lingotto Innovation, and Obvious Ventures. The funding will support Mosaic's development of full-stack intelligent surgical machines designed to extend the reach and precision of surgical expertise.
Mosaic's initial focus is endovascular intervention, a category of procedures in which physicians guide flexible wires and catheters through blood vessels to deliver treatment. Targeting this segment first positions the company in a area of minimally invasive care where precision navigation is central to clinical outcomes.
The source material does not provide further detail on valuation, timeline to clinical deployment, regulatory status, or leadership, and this summary does not extrapolate beyond the announced funding and product direction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.